Board and Management Changes

Sep 7, 2026 at 7:49 PM EDT · Issued by Neurotech International Ltd. via ASX

Filed with ASX · Sep 7, 2026 at 7:49 PM EDT

On 6ix: 6ix.com/news/board-and-management-changes-98

ASX Announcement Neurotech International Ltd Suite 102 / Level 1, 55 Collins Street, Melbourne, VIC 3000 T: 03 9498 3132 E: info@neurotechinternational.com W: neurotechinternational.com ABN: 73 610 205 402 ASX: NTI 1 of 2 8 September 2026 Board and Management Changes Neurotech International...

View Attachment

6ix hasn’t read this filing yet.

Neurotech International Ltd. on 6ix

Earlier from Neurotech International

Final Director's Interest NoticeSep 7
Appendix 4G and Corporate Governance StatementAug 26
Appendix 4E & Annual Report to shareholdersAug 26
Appointment of Executive ChairmanAug 16
Becoming a substantial holderAug 12

Later from Neurotech International

Notification of cessation of securities - NTISep 8
Initial Director's Interest NoticeSep 8
NTI Doses First Patient in Phase 3 Beyond Harmony ASD StudySep 20
Notice of Annual General Meeting/Proxy FormOct 1
Annual Report (Typeset)Oct 5

All Neurotech International news releases

Follow Neurotech International into a list and get an email when it puts out news.

Follow Neurotech International